StockNews.AI
CNC
StockNews.AI
43 days

INVESTIGATION ALERT: Edelson Lechtzin LLP Announces an Investigation of Centene Corporation (NYSE: CNC) and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm

1. Centene Corporation facing investigations for possible securities law violations. 2. Company withdrew 2025 earnings guidance due to poor market conditions. 3. Stock price plummeted 40.37% following negative earnings forecast.

4m saved
Insight
Article

FAQ

Why Very Bearish?

The stock's drastic drop due to earnings guidance withdrawal aligns with precedent cases of investor distrust impacting share prices significantly.

How important is it?

Allegations and stock price drop indicate serious repercussions for company performance and investor sentiment.

Why Short Term?

Immediate investor reaction observed; potential for further declines in the near term.

Related Companies

UNHAETANTM
NEWTOWN, Pa., July 07, 2025 (GLOBE NEWSWIRE) -- Edelson Lechtzin LLP is investigating potential violations of the federal securities laws involving Centene Corporation (“Centene”) (NYSE: CNC), resulting from allegations of providing potentially misleading business information to the investing public. If you have non-public information that could assist in the Centene investigation, or if you are a Centene investor who suffered a loss and would like to learn more, you can provide your information HERE. You can also contact attorney Eric Lechtzin of Edelson Lechtzin LLP by calling 844-563-5550 or via e-mail at elechtzin@edelson-law.com. ABOUT THE COMPANY: Centene is a managed healthcare company specializing in government-sponsored programs, such as Medicaid and Medicare, as well as health insurance plans on individual exchanges and commercial marketplaces. THE ALLEGED WRONGDOING: On July 1, 2025, Centene announced its intention to withdraw its 2025 earnings guidance due to declining market growth in 22 out of the 29 states covered by its insurance marketplace. Specifically, Centene stated that overall health risks in these states were much higher than initially anticipated in its original risk adjustment calculations. On this news, the price of Centene stock fell $22.87 per share, or 40.37%, to close at $33.78 per share on July 2, 2025. ABOUT EDELSON LECHTZIN LLP: Edelson Lechtzin LLP is a national class action law firm with offices in Pennsylvania and California. In addition to cases involving securities and investment fraud, our lawyers focus on class action cases alleging violations of federal antitrust laws, employee benefit plans under ERISA, wage theft, data security breaches, and consumer protection. For more information, please contact: Marc H. Edelson, Esq.Eric Lechtzin, Esq.EDELSON LECHTZIN LLP411 S. State Street, Suite N-300Newtown, PA 18940Phone: 844-696-7492 or 215-867-2399 ext. 1 Email: medelson@edelson-law.com Email: elechtzin@edelson-law.comWeb: www.edelson-law.com This press release may be considered Attorney Advertising in some jurisdictions. No class has been certified in this case, so you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. Your ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Related News